Clinical Trial Update: The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cyclosporine with T-cell add-back in blood cell transplant settings for hematologic cancers, including chronic lymphocytic leukemia and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Graft-versus-host Disease
• Hematologic Neoplasm
• Multiple Myeloma
• Myelodysplastic Syndrome

Drugs mentioned

• CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Chronic Lymphocytic Leukemia, Graft vs Host Disease | Phase 2 | Status: COMPLETED